Brain activity in movement disorders: basal ganglia, thalamus, and cerebellum
Official title: Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders
Run by University of Pennsylvania · NCT06848530 · Data updated 2026-11-12
We will record brain electrical signals from adults with movement disorders, both with and without deep brain stimulators, to see if specific signal patterns match their symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | December 10, 2025 |
| Main results expected | April 2030 |
| Study ends | April 2030 |
| Registry record updated | July 14, 2026 |
| Trial ID | NCT06848530 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) diagnosed by a movement disorders neurologist with Parkinson's disease, dystonia, tremor (including essential tremor), cerebellar ataxia, or other hyperkinetic movement disorders, with or without an implanted DBS device, who do not have dementia.
✕Probably not a fit
Patients with dementia, severe cognitive impairment, or those unable to travel to the study site are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This protocol records electrical brain activity from the scalp and, when available, from implanted deep brain stimulators in adults with Parkinson's disease, tremor, dystonia, cerebellar ataxia, or other hyperkinetic disorders. Recordings include noninvasive scalp electrodes and device-based sensing from compatible DBS systems, and data are collected alongside clinical measures of movement symptoms. Some participants may have medication adjustments or DBS programming changes as part of the protocol to capture different symptom states. The resulting signals are analyzed to identify neural signatures linked to symptom fluctuations that could inform biomarkers or future therapy adjustments.
Why it matters
Potential benefit: If successful, this work could identify brain signal markers that help personalize DBS settings or guide new symptom-targeting treatments.
How similar studies have gone: Prior work using scalp EEG and sensing-enabled DBS devices has produced promising biomarkers of movement symptoms, but translating these findings into routine clinical tools remains ongoing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients 18 years of age and above * Any patient who has been diagnosed by a movement disorders neurologist with one of the following movement disorders: * Parkinson's disease * Dystonia * Tremor, including essential tremor * Cerebellar ataxia * Other hyperkinetic movement disorders, such as chorea and tics Exclusion Criteria: \- Patients with dementia
Where it's running
-
Pennsylvania Hospital
Philadelphia, Pennsylvania, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Developing algorithms to restore complex movement after paralysis using non-invasive sensors in healthy volunteers
This project tests whether signals from non-invasive sensors worn by healthy volunteers can train algorithms to control computers or assistive devices that might help people with paralysis.
-
Long-read genome sequencing to help diagnose dystonia
Researchers test long-read genome sequencing to see if it can provide a genetic diagnosis for people with dystonia and related movement disorders when standard tests have not.
-
Registry and natural history of epilepsy-dyskinesia syndromes
This registry will collect health data and biological samples from people of all ages who have a genetic diagnosis of epilepsy-dyskinesia syndromes to see how their genes relate to their movement and seizure symptoms over time.
-
Registry and biobank for neuroimmunological diseases
This study is trying to see if certain antibodies in the brain are linked to neurological disorders like encephalopathy and psychosis, and how they might affect patients' health.
-
Mindfulness program for people with Parkinson's and their caregivers
This study tests whether a mindfulness program can help people with Parkinson's and their caregivers feel better emotionally and improve their relationship.
-
Collecting data on neurodegenerative diseases progression markers
This study is trying to find new signs that can help doctors understand how neurodegenerative diseases like Parkinson's progress, so they can improve early treatment options for patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.